Phase II trial of weekly docetaxel for patients with relapsed ovarian cancer who have previously received paclitaxel--ANZGOG 02-01.

Source:http://linkedlifedata.com/resource/pubmed/id/17079006

Download in:

View as

General Info

PMID
17079006